A Pilot Study of Acupoint Injection for Primary Dysmenorrhea
Condition: Dysmenorrhea; Pain, Menstrual
MeSH terms: Dysmenorrhea
Study type: Interventional

Summary: 
      Many women, particularly adolescent women, suffer from painful menstrual cramps, medically
      referred to as dysmenorrhea. Common treatments for menstrual cramps are non-steroidal
      anti-inflammatory drugs and oral contraceptives, but both have side effects that limit their
      use. Injection of vitamin K into an acupuncture point has been used as treatment for
      dysmenorrhea at the Obstetrics & Gynecology Hospital in Shanghai, China since at least 1985.
      More research is needed on the effectiveness of this treatment and its acceptability to
      different women. The objective of this study is to examine the feasibility and effectiveness
      of acupoint injection of vitamin K1 for the treatment of severe primary dysmenorrhea in the
      United States. Twenty participants will be randomized to receive either 1) vitamin K1
      injection into an acupuncture point at the start of their menstrual cycle followed by a
      saline injection in a non-acupuncture point two months later or 2) saline injection in a
      non-acupuncture point followed by vitamin K1 injection into an acupuncture point two months
      later. The primary outcome measure will be change in pain intensity measured before and after
      each treatment. Data on other menstrual symptoms will be collected by telephone or a
      web-based survey. Three additional participants will be recruited to receive vitamin K1
      injection into an acupuncture point and have blood samples drawn before and after injection
      to determine absorption of vitamin K1. The aims of the study are to collect preliminary data
      on the efficacy and safety of vitamin K1 injected in an acupoint for the treatment of severe
      primary dysmenorrhea; assess the feasibility and acceptability of the treatment among U.S.
      women; and test the blood absorption of vitamin K1 following acupoint injection treatment.

      The investigators hypothesize that:

        1. Vitamin K1 acupoint injection is a safe treatment for women with menstrual pain.

        2. Vitamin K1 acupoint injection reduces menstrual pain more than placebo saline injection
           does.

        3. The treatment of vitamin K1 acupoint injection is acceptable to U.S. women.

        4. Vitamin K1 is absorbed into the blood thru acupoint injection.
    


Intervention name(s): Vitamin K acupoint injection; Saline Injection
Intervention type(s): Other; Other
Intervention description(s): Vitamin K will be injected into an acupuncture point within 2 days of the onset of painful menstrual cramps. Injections of 5 mg/0.5ml of vitamin K1 will be administered in bilateral acupuncture points. A single shot of vitamin K1 is 10mg/ml. Five mg/0.5ml will be drawn twice from one ampule and injected into each bilateral site, for a total dose of 10mg/ml of vitamin K.; Injection of .5ml saline bilaterally into both legs within 2 days of the onset of painful menstrual cramps.
Intervention MeSH terms: Vitamin K
Allocation: Randomized
Intervention model: Crossover Assignment
Masking: Single (Participant)
Primary purpose: Treatment
Keywords: acupuncture; menstrual pain; dysmenorrhea; menstrual cramps; vitamin K1